Novartis Pharmaceuticals — East Hanover, New Jersey

Novartis Pharmaceuticals is a clinical research site located in East Hanover, New Jersey, United States 07936.

Crixeo Clinical Trials Trust Score: 30/100 (FAILING). This profile has not yet been claimed by the site owner.

Novartis Pharmaceuticals has participated in 80 clinical trials.

Therapeutic areas: Hypertension, Heart Failure, Sickle Cell Disease.

Sponsors: Novartis, Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in East Hanover

Browse all research sites in New Jersey · View every site in East Hanover

• Beth Israel Hospital
• Novartis
• Novartis Investigative Site
• Kessler Foundation
• sites in USA
• Novartis Pharmaceuticals Corporation
• Novartis Investigational site
• Investigative Site
• Novartis USA
• For US Site Information, contact Novartis Pharmaceuticals
• For information regarding facilities, please contact the Central Contact

Sponsor Feasibility Report

Trust Score: 30/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Pharmaceuticals?

Novartis Pharmaceuticals has a Crixeo Trust Score of 30/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Pharmaceuticals conducted?

Novartis Pharmaceuticals has 80 clinical trials on record. Their work covers Hypertension, Heart Failure, Sickle Cell Disease.

Is Novartis Pharmaceuticals accredited by Crixeo Clinical Trials?

Novartis Pharmaceuticals has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novartis Pharmaceuticals?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.